S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
S&P 500   0.54 (-1.29%)
DOW   0.54 (-1.29%)
QQQ   274.64 (+1.32%)
AAPL   455.61 (+3.49%)
MSFT   216.35 (+1.60%)
FB   265.28 (+6.49%)
GOOGL   1,504.95 (+1.75%)
AMZN   3,225.00 (+0.62%)
NVDA   453.42 (+0.43%)
CGC   17.52 (-8.80%)
BABA   265.68 (+0.29%)
TSLA   1,489.58 (+0.31%)
MU   48.70 (-4.60%)
GE   6.33 (-1.09%)
AMD   86.71 (+1.64%)
T   29.84 (-0.03%)
F   6.93 (-0.43%)
ACB   10.31 (-3.73%)
GILD   68.81 (-0.28%)
NFLX   509.08 (+1.39%)
DIS   130.82 (+2.52%)
BAC   25.47 (+0.32%)
BA   172.20 (-1.19%)
Log in

LON:AZNAstraZeneca News Headlines

GBX 8,419
-81.00 (-0.95 %)
(As of 08/6/2020 04:00 PM ET)
Add
Compare
Today's Range
8,398
Now: GBX 8,419
8,518
50-Day Range
8,344
MA: GBX 8,618.04
9,320
52-Week Range
83.80
Now: GBX 8,419
9,537.09
Volume1.16 million shs
Average Volume2.31 million shs
Market Capitalization£110.48 billion
P/E Ratio51.43
Dividend Yield2.47%
BetaN/A

Headlines

AstraZeneca (LON AZN) News Headlines

Source:
DateHeadline
Pfizer (PFE), BioNTech BNTX) Land Multi-Billion Dollar Order for Vaccine (AZN)Pfizer (PFE), BioNTech BNTX) Land Multi-Billion Dollar Order for Vaccine (AZN)
marketbeat.com - August 3 at 2:09 PM
AstraZeneca in first COVID-19 vaccine deal with Chinese company - Yahoo FinanceAstraZeneca in first COVID-19 vaccine deal with Chinese company - Yahoo Finance
finance.yahoo.com - August 6 at 6:05 PM
Brazil decree to provide $356 million for coronavirus vaccineBrazil decree to provide $356 million for coronavirus vaccine
finance.yahoo.com - August 6 at 6:05 PM
AstraZeneca in first COVID-19 vaccine deal with Chinese company - ReutersAstraZeneca in first COVID-19 vaccine deal with Chinese company - Reuters
reuters.com - August 6 at 8:01 AM
AstraZeneca in first COVID-19 vaccine deal with Chinese companyAstraZeneca in first COVID-19 vaccine deal with Chinese company
finance.yahoo.com - August 6 at 8:01 AM
A Look Into AstraZeneca's Price Over EarningsA Look Into AstraZeneca's Price Over Earnings
finance.yahoo.com - August 3 at 1:27 PM
Credit Suisse Group Analysts Give AstraZeneca (LON:AZN) a GBX 9,500 Price TargetCredit Suisse Group Analysts Give AstraZeneca (LON:AZN) a GBX 9,500 Price Target
www.americanbankingnews.com - August 3 at 6:47 AM
Goldman Sachs Group Reiterates "Sell" Rating for AstraZeneca (LON:AZN)Goldman Sachs Group Reiterates "Sell" Rating for AstraZeneca (LON:AZN)
www.americanbankingnews.com - August 3 at 6:13 AM
Big Pharma Shouldn’t Be Too GreedyBig Pharma Shouldn’t Be Too Greedy
finance.yahoo.com - August 2 at 7:11 PM
DZ Bank Boosts AstraZeneca (LON:AZN) Price Target to GBX 7,500DZ Bank Boosts AstraZeneca (LON:AZN) Price Target to GBX 7,500
www.americanbankingnews.com - July 31 at 7:01 AM
AstraZeneca tops estimates as coronavirus vaccine hopes persist - ReutersAstraZeneca tops estimates as coronavirus vaccine hopes persist - Reuters
www.reuters.com - July 31 at 1:21 AM
AstraZeneca Reports Q2 Earnings Beat On The Back Of A Diversified Drug Portfolio - Yahoo FinanceAstraZeneca Reports Q2 Earnings Beat On The Back Of A Diversified Drug Portfolio - Yahoo Finance
finance.yahoo.com - July 31 at 1:21 AM
How Does AstraZenecas Debt Look Like? - Yahoo FinanceHow Does AstraZeneca's Debt Look Like? - Yahoo Finance
finance.yahoo.com - July 31 at 1:21 AM
AstraZeneca to be exempt from coronavirus vaccine liability claims in most countries - ReutersAstraZeneca to be exempt from coronavirus vaccine liability claims in most countries - Reuters
www.reuters.com - July 31 at 1:21 AM
AstraZeneca plc (LON:AZN) to Issue Dividend of GBX 69.60AstraZeneca plc (LON:AZN) to Issue Dividend of GBX 69.60
www.americanbankingnews.com - July 30 at 7:16 PM
AstraZeneca Earnings Beat Estimates - BloombergAstraZeneca Earnings Beat Estimates - Bloomberg
www.bloomberg.com - July 30 at 10:16 AM
AstraZeneca beats Q2 consensus; guidance maintained - Seeking AlphaAstraZeneca beats Q2 consensus; guidance maintained - Seeking Alpha
seekingalpha.com - July 30 at 10:16 AM
AstraZeneca and Sanofis nirsevimab successful in mid-stage study - Seeking AlphaAstraZeneca and Sanofi's nirsevimab successful in mid-stage study - Seeking Alpha
seekingalpha.com - July 30 at 10:16 AM
AstraZeneca vaccine trials underway, profit soars - MarketWatchAstraZeneca vaccine trials underway, profit soars - MarketWatch
www.marketwatch.com - July 30 at 10:16 AM
Barclays Boosts AstraZeneca (LON:AZN) Price Target to GBX 9,300Barclays Boosts AstraZeneca (LON:AZN) Price Target to GBX 9,300
www.americanbankingnews.com - July 29 at 1:27 PM
AstraZenecas (AZN) Outperform Rating Reiterated at Credit Suisse GroupAstraZeneca's (AZN) Outperform Rating Reiterated at Credit Suisse Group
www.americanbankingnews.com - July 29 at 1:27 PM
A Look Into AstraZenecas DebtA Look Into AstraZeneca's Debt
www.benzinga.com - July 29 at 1:22 PM
AstraZeneca Q2 2020 Earnings PreviewAstraZeneca Q2 2020 Earnings Preview
seekingalpha.com - July 29 at 1:22 PM
AstraZenecas Farxiga meets chronic kidney disease trial main goalAstraZeneca's Farxiga meets chronic kidney disease trial main goal
www.nasdaq.com - July 29 at 8:21 AM
AstraZenecas Farxiga successful in late-stage kidney disease studyAstraZeneca's Farxiga successful in late-stage kidney disease study
seekingalpha.com - July 29 at 8:21 AM
Moderna Is Asking $60 for Covid-19 Vaccine, According to Report, Drawing Criticism From Capitol HillModerna Is Asking $60 for Covid-19 Vaccine, According to Report, Drawing Criticism From Capitol Hill
finance.yahoo.com - July 28 at 10:20 PM
AstraZeneca (LON:AZN) Receives Media Impact Rating of 0.22AstraZeneca (LON:AZN) Receives Media Impact Rating of 0.22
www.americanbankingnews.com - July 28 at 12:28 PM
4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront - Motley Fool4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront - Motley Fool
www.fool.com - July 28 at 12:18 PM
Top Ranked Income Stocks to Buy for July 28thTop Ranked Income Stocks to Buy for July 28th
finance.yahoo.com - July 28 at 12:18 PM
Germany's IDT warns against equipment price hike in scramble for COVID-19 vaccineGermany's IDT warns against equipment price hike in scramble for COVID-19 vaccine
finance.yahoo.com - July 28 at 12:18 PM
AstraZeneca (LON:AZN) Given a GBX 9,000 Price Target at Credit Suisse GroupAstraZeneca (LON:AZN) Given a GBX 9,000 Price Target at Credit Suisse Group
www.americanbankingnews.com - July 28 at 8:58 AM
AstraZeneca (LON:AZN) PT Set at GBX 6,000 by Goldman Sachs GroupAstraZeneca (LON:AZN) PT Set at GBX 6,000 by Goldman Sachs Group
www.americanbankingnews.com - July 28 at 7:33 AM
AstraZeneca kidney drug meets all endpoints - MarketWatchAstraZeneca kidney drug meets all endpoints - MarketWatch
www.marketwatch.com - July 28 at 7:18 AM
4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront
finance.yahoo.com - July 28 at 7:18 AM
FARXIGA Met All Primary and Secondary Endpoints in Groundbreaking Phase III DAPA-CKD Trial for the Treatment of Patients With Chronic Kidney DiseaseFARXIGA Met All Primary and Secondary Endpoints in Groundbreaking Phase III DAPA-CKD Trial for the Treatment of Patients With Chronic Kidney Disease
finance.yahoo.com - July 28 at 7:18 AM
WRAPUP 1-Moderna, Pfizer start decisive COVID-19 vaccine trials, eye year-end launchesWRAPUP 1-Moderna, Pfizer start decisive COVID-19 vaccine trials, eye year-end launches
finance.yahoo.com - July 27 at 9:13 PM
PRESS DIGEST-British Business - July 28PRESS DIGEST-British Business - July 28
finance.yahoo.com - July 27 at 9:13 PM
AstraZeneca to Pay Daiichi Up to $6 Billion for New Cancer Drug - BloombergAstraZeneca to Pay Daiichi Up to $6 Billion for New Cancer Drug - Bloomberg
www.bloomberg.com - July 27 at 11:13 AM
Emergent to provide manufacturing services on AstraZenecas COVID-19 vaccine - MarketWatchEmergent to provide manufacturing services on AstraZeneca's COVID-19 vaccine - MarketWatch
www.marketwatch.com - July 27 at 11:13 AM
AstraZeneca Strikes $6 Billion Cancer Drug Deal - The Wall Street JournalAstraZeneca Strikes $6 Billion Cancer Drug Deal - The Wall Street Journal
www.wsj.com - July 27 at 11:13 AM
AstraZeneca To Pay Up To $6B For Daiichi Cancer Drug DealAstraZeneca To Pay Up To $6B For Daiichi Cancer Drug Deal
finance.yahoo.com - July 27 at 11:12 AM
AstraZeneca (LON:AZN) Receives Sell Rating from UBS GroupAstraZeneca (LON:AZN) Receives Sell Rating from UBS Group
www.americanbankingnews.com - July 27 at 10:26 AM
JPMorgan Chase & Co. Analysts Give AstraZeneca (LON:AZN) a GBX 9,500 Price TargetJPMorgan Chase & Co. Analysts Give AstraZeneca (LON:AZN) a GBX 9,500 Price Target
www.americanbankingnews.com - July 27 at 8:22 AM
AstraZeneca (LON:AZN) Stock Rating Reaffirmed by Shore CapitalAstraZeneca (LON:AZN) Stock Rating Reaffirmed by Shore Capital
www.americanbankingnews.com - July 27 at 6:33 AM
AstraZeneca, Daiichi Sankyo in $6B oncology deal - MarketWatchAstraZeneca, Daiichi Sankyo in $6B oncology deal - MarketWatch
www.marketwatch.com - July 27 at 6:12 AM
AstraZeneca to pay up to $6 bln in new cancer drug deal with DaiichiAstraZeneca to pay up to $6 bln in new cancer drug deal with Daiichi
finance.yahoo.com - July 27 at 6:12 AM
AstraZeneca bets up to $6 billion on new Daiichi cancer drugAstraZeneca bets up to $6 billion on new Daiichi cancer drug
finance.yahoo.com - July 27 at 6:12 AM
Is Moderna Stock a Buy?Is Moderna Stock a Buy?
finance.yahoo.com - July 26 at 7:36 AM
5 Late-Stage COVID-19 Vaccines: Which Is Likely to Be the Biggest Winner?5 Late-Stage COVID-19 Vaccines: Which Is Likely to Be the Biggest Winner?
finance.yahoo.com - July 26 at 7:36 AM
AstraZeneca plc (LON:AZN) Receives Average Recommendation of "Hold" from BrokeragesAstraZeneca plc (LON:AZN) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 25 at 6:41 AM
European advisory group backs AstraZenecas Calquence for leukemia treatment - Seeking AlphaEuropean advisory group backs AstraZeneca's Calquence for leukemia treatment - Seeking Alpha
seekingalpha.com - July 24 at 5:40 PM
This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.